Korro Bio Inc (KRRO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 21,824 | 55,643 | 166,150 | 36,333 | 79,635 |
| Marketable Securities | 53,332 | 70,452 | N/A | 18,915 | 51,072 |
| Receivables | 969 | 1,696 | N/A | N/A | N/A |
| Other current assets | 0 | 0 | 3,563 | 603 | 0 |
| TOTAL | $82,372 | $131,532 | $172,728 | $57,083 | $134,748 |
| Non-Current Assets | |||||
| PPE Net | 8,164 | 27,710 | 15,665 | 9,866 | 5,522 |
| Investments And Advances | 10,031 | 36,959 | 0 | 0 | 11,719 |
| Other Non-Current Assets | 12,939 | 30,039 | 33,270 | 6,793 | 33,369 |
| TOTAL | $31,134 | $94,708 | $48,935 | $16,659 | $50,610 |
| Total Assets | $113,506 | $226,240 | $221,663 | $73,742 | $185,358 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | N/A | 833 |
| Accounts payable and accrued liabilities | 1,651 | 3,992 | 7,280 | 2,605 | 2,748 |
| Accrued Expenses | 7,614 | 6,171 | 10,212 | 3,175 | 6,101 |
| TOTAL | $11,937 | $14,960 | $19,483 | $8,701 | $11,429 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | N/A | 14,167 |
| Deferred Revenues | N/A | 3,513 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 42,295 | 44,953 | 32,269 | 209 | 28,938 |
| TOTAL | $50,130 | $50,865 | $32,269 | $209 | $43,105 |
| Total Liabilities | $62,067 | $65,825 | $51,752 | $8,910 | $54,534 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 14,423 | 9,389 | 8,022 | 706 | 700 |
| Common Shares | 9 | 9 | 8 | N/A | 35 |
| Retained earnings | -383,846 | -266,586 | -183,005 | -101,833 | -180,085 |
| Other shareholders' equity | 212 | 268 | 0 | 163,858 | -62 |
| TOTAL | $51,439 | $160,415 | $169,911 | $64,832 | $130,824 |
| Total Liabilities And Equity | $113,506 | $226,240 | $221,663 | $73,742 | $185,358 |